{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:34:04Z","timestamp":1781649244220,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109292","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:11:12Z","timestamp":1779293472000},"source":"Crossref","is-referenced-by-count":1,"title":["Neonatal Lactic Acidosis Associated With Antiretroviral Exposure: A Case Report"],"prefix":"10.7759","author":[{"given":"Joanna","family":"Mercado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiza","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Droz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolymar","family":"Poventud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Andino-Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Mother-to-child transmission of HIV. (2022). Accessed. September 22, 2025: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/prevention\/mother-to-child-transmission-of-hiv."},{"key":"ref2","unstructured":"Preventing perinatal transmission of HIV during pregnancy and childbirth. (2021). Accessed. September 22, 2025: https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/preventing-perinatal-transmission-hiv-during-pregnancy-and-chil...."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.0141","article-title":"Association of risk of viremia, immunosuppression, serious clinical events, and mortality with increasing age in perinatally human immunodeficiency virus-infected youth","volume":"171","author":"Neilan AM","year":"2017","unstructured":"Neilan AM, Karalius B, Patel K, et al.. Association of risk of viremia, immunosuppression, serious clinical events, and mortality with increasing age in perinatally human immunodeficiency virus-infected youth. JAMA Pediatr. 2017, 171:450-60. 10.1001\/jamapediatrics.2017.0141","journal-title":"JAMA Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-013-0325-8","article-title":"A review of the toxicity of HIV medications","volume":"10","author":"Margolis AM","year":"2014","unstructured":"Margolis AM, Heverling H, Pham PA, Stolbach A. A review of the toxicity of HIV medications. J Med Toxicol. 2014, 10:26-39. 10.1007\/s13181-013-0325-8","journal-title":"J Med Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm411","article-title":"HIV and mitochondrial toxicity in children","volume":"61","author":"Foster C","year":"2008","unstructured":"Foster C, Lyall H. HIV and mitochondrial toxicity in children. J Antimicrob Chemother. 2008, 61:8-12. 10.1093\/jac\/dkm411","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and therapeutic approach to elevated lactate levels","volume":"88","author":"Andersen LW","year":"2013","unstructured":"Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc. 2013, 88:1127-140.","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2014.05.007","article-title":"Comprehensive review on lactate metabolism in human health","volume":"17","author":"Adeva-Andany M","year":"2014","unstructured":"Adeva-Andany M, L\u00f3pez-Oj\u00e9n M, Funcasta-Calder\u00f3n R, Ameneiros-Rodr\u00edguez E, Donapetry-Garc\u00eda C, Vila-Altesor M, Rodr\u00edguez-Seijas J. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014, 17:76-100. 10.1016\/j.mito.2014.05.007","journal-title":"Mitochondrion"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"Lewis W","year":"1995","unstructured":"Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995, 1:417-22. 10.1038\/nm0595-417","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)90004-3","article-title":"Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity","volume":"22","author":"Kakuda TN","year":"2000","unstructured":"Kakuda TN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 2000, 22:685-708. 10.1016\/S0149-2918(00)90004-3","journal-title":"Clin Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1021\/tx100186t","article-title":"Protein adducts as prospective biomarkers of nevirapine toxicity","volume":"23","author":"Antunes AM","year":"2010","unstructured":"Antunes AM, Godinho AL, Martins IL, et al.. Protein adducts as prospective biomarkers of nevirapine toxicity. Chem Res Toxicol. 2010, 23:1714-25. 10.1021\/tx100186t","journal-title":"Chem Res Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09321-y","article-title":"Nevirapine induced mitochondrial dysfunction in HepG2 cells","volume":"7","author":"Paemanee A","year":"2017","unstructured":"Paemanee A, Sornjai W, Kittisenachai S, Sirinonthanawech N, Roytrakul S, Wongtrakul J, Smith DR. Nevirapine induced mitochondrial dysfunction in HepG2 cells. Sci Rep. 2017, 7:9194. 10.1038\/s41598-017-09321-y","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113998","article-title":"Nevirapine biotransformation insights: an integrated in vitro approach unveils the Biocompetence and Glutathiolomic profile of a human hepatocyte-like cell 3D model","volume":"21","author":"Cipriano M","year":"2020","unstructured":"Cipriano M, Pinheiro PS, Sequeira C, et al.. Nevirapine biotransformation insights: an integrated in vitro approach unveils the Biocompetence and Glutathiolomic profile of a human hepatocyte-like cell 3D model. Int J Mol Sci. 2020, 21:3998. 10.3390\/ijms21113998","journal-title":"Int J Mol Sci"},{"key":"ref13","unstructured":"Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. (2025). Accessed. March 31, 2026: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/perinatal\/recommendations-arv-drugs-pregnancy-overview."},{"key":"ref14","unstructured":"Guidelines for the use of antiretroviral agents in pediatric HIV infection. (2024). Accessed. March 31, 2026: https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/pediatric-arv\/guidelines-pediatric-arv.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000134943","article-title":"Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy","volume":"82","author":"Scruggs ER","year":"2008","unstructured":"Scruggs ER, Dirks Naylor AJ. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology. 2008, 82:83-8. 10.1159\/000134943","journal-title":"Pharmacology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25149","article-title":"Mitochondrial and oxidative stress response in HepG2 cells following acute and prolonged exposure to antiretroviral drugs","volume":"116","author":"Nagiah S","year":"2015","unstructured":"Nagiah S, Phulukdaree A, Chuturgoon A. Mitochondrial and oxidative stress response in HepG2 cells following acute and prolonged exposure to antiretroviral drugs. J Cell Biochem. 2015, 116:1939-46. 10.1002\/jcb.25149","journal-title":"J Cell Biochem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01443-18","article-title":"Zidovudine-mediated autophagy inhibition enhances mitochondrial toxicity in muscle cells","volume":"63","author":"Lin H","year":"2019","unstructured":"Lin H, Stankov MV, Hegermann J, Budida R, Panayotova-Dimitrova D, Schmidt RE, Behrens GM. Zidovudine-mediated autophagy inhibition enhances mitochondrial toxicity in muscle cells. Antimicrob Agents Chemother. 2019, 63:01443. 10.1128\/AAC.01443-18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1","volume":"285","author":"Mandelbrot L","year":"2001","unstructured":"Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al.. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001, 285:2083-93. 10.1001\/jama.285.16.2083","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biology12040580","article-title":"Antiretrovirals promote metabolic syndrome through mitochondrial stress and dysfunction: an in vitro study","volume":"12","author":"Mohan J","year":"2023","unstructured":"Mohan J, Ghazi T, Sibiya T, Chuturgoon AA. Antiretrovirals promote metabolic syndrome through mitochondrial stress and dysfunction: an in vitro study. Biology (Basel). 2023, 12:580. 10.3390\/biology12040580","journal-title":"Biology (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001291","article-title":"Nevirapine pharmacokinetics and safety in neonates receiving combination antiretroviral therapy for prevention of vertical HIV transmission","volume":"74","author":"Lau E","year":"2017","unstructured":"Lau E, Brophy J, Samson L, et al.. Nevirapine pharmacokinetics and safety in neonates receiving combination antiretroviral therapy for prevention of vertical HIV transmission. J Acquir Immune Defic Syndr. 2017, 74:493-8. 10.1097\/QAI.0000000000001291","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku262","article-title":"Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz","volume":"69","author":"Blas-Garc\u00eda A","year":"2014","unstructured":"Blas-Garc\u00eda A, Polo M, Alegre F, Funes HA, Mart\u00ednez E, Apostolova N, Esplugues JV. Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz. J Antimicrob Chemother. 2014, 69:2995-3000. 10.1093\/jac\/dku262","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216712","article-title":"Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: randomized crossover clinical trial in healthy volunteers","volume":"14","author":"Barroso S","year":"2019","unstructured":"Barroso S, Mor\u00e9n C, Gonz\u00e1lez-Segura \u00c0, et al.. Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: randomized crossover clinical trial in healthy volunteers. PLoS One. 2019, 14:e0216712. 10.1371\/journal.pone.0216712","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000316","article-title":"Raltegravir pharmacokinetics and safety in neonates following maternal dosing","volume":"67","author":"Clarke DF","year":"2014","unstructured":"Clarke DF, Acosta EP, Rizk ML, et al.. Raltegravir pharmacokinetics and safety in neonates following maternal dosing. J Acquir Immune Defic Syndr. 2014, 67:310-15. 10.1097\/QAI.0000000000000316","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1179\/027249309X12547917868880","article-title":"Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy","volume":"29","author":"Shah I","year":"2009","unstructured":"Shah I. Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy. Ann Trop Paediatr. 2009, 29:257-61. 10.1179\/027249309X12547917868880","journal-title":"Ann Trop Paediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000086400.93257.74","article-title":"Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy","volume":"22","author":"Alimenti A","year":"2003","unstructured":"Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr Infect Dis J. 2003, 22:782-9. 10.1097\/01.inf.0000086400.93257.74","journal-title":"Pediatr Infect Dis J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182013000600012","article-title":"Prevention of vertical transmission and side effects of antiretroviral therapy in children born to HIV-positive South Eastern area of Santiago, Chile: 15-years perspective [Article in Spanish]","volume":"30","author":"Pe\u00f1a A","year":"2013","unstructured":"Pe\u00f1a A, Cer\u00f3n I, Budnik I, et al.. Prevention of vertical transmission and side effects of antiretroviral therapy in children born to HIV-positive South Eastern area of Santiago, Chile: 15-years perspective [Article in Spanish]. Rev Chilena Infectol. 2013, 30:644-52. 10.4067\/S0716-10182013000600012","journal-title":"Rev Chilena Infectol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001217","article-title":"Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial","volume":"9","author":"Gibb DM","year":"2012","unstructured":"Gibb DM, Kizito H, Russell EC, et al.. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med. 2012, 9:e1001217. 10.1371\/journal.pmed.1001217","journal-title":"PLoS Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/2042098613485276","article-title":"Is tenofovir\/emtricitabine teratogenic?","volume":"4","author":"Jibril M","year":"2013","unstructured":"Jibril M, Egunsola O. Is tenofovir\/emtricitabine teratogenic?. Ther Adv Drug Saf. 2013, 4:115-17. 10.1177\/2042098613485276","journal-title":"Ther Adv Drug Saf"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5801","article-title":"The Antiretroviral Pregnancy Registry: three decades of prospective monitoring for birth defects","volume":"33","author":"Albano JD","year":"2024","unstructured":"Albano JD, Scheuerle AE, Watts DH, et al.. The Antiretroviral Pregnancy Registry: three decades of prospective monitoring for birth defects. Pharmacoepidemiol Drug Saf. 2024, 33:e5801. 10.1002\/pds.5801","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/472532-neonatal-lactic-acidosis-associated-with-antiretroviral-exposure-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:11:20Z","timestamp":1779293480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/472532-neonatal-lactic-acidosis-associated-with-antiretroviral-exposure-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.109292","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}